Genomics company Illumina (NASDAQ:ILMN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Bionano Genomics Inc. (NASDAQ:BNGO) stock has tumbled to a 52-week low, touching down at $4.9 as the company faces a challenging market environment. According to InvestingPro data, the stock's RSI ...

Tempus AI (NASDAQ: TEM) wasn’t that remarkable compared to most other AI high-fliers in the past year. The stock was very ...

Detailed price information for GX Genomics & Biotechnology ETF (GNOM-Q) from The Globe and Mail including charting and trades.

Nvidia leverages AI platforms like BioNeMo to disrupt drug discovery, genomics, and clinical trials. Scalable solutions like Nvidia AI Enterprise ensure recurring revenue and accessibility across ...

This article delves into the fundamentals, applications, and future prospects of CRISPR screening libraries, highlighting their transformative potential in functional genomics and biotechnology.

Our goal is to provide a new perspective on the significance of this integrated approach and its implications for future practices and research in rabbit production, emphasizing the need for continued ...

TEM's strong fundamentals and competitive position, bolstered by the Ambry acquisition, support long-term growth, particularly in diagnostics and expanding AI applications across healthcare.